Date	Period	Revenue/Estimate	Earnings Call
Nov 13, 2024	2024/Q3	9.000M / --	--
May 15, 2024	2024/Q1	11.000M / --	--
Nov 13, 2023	2023/Q3	73.000M / --	--
May 15, 2023	2023/Q1	220.000M / --	--
Nov 14, 2022	2022/Q3	296.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Nov 13, 20242024/Q39.000M / ----

May 15, 20242024/Q111.000M / ----

Nov 13, 20232023/Q373.000M / ----

May 15, 20232023/Q1220.000M / ----

Nov 14, 20222022/Q3296.000M / ----

Unlock Free Earnings Estimates

Open Account

Solasia Pharma KK: Notice regarding revisions to full-year earnings forecasts and the status of derivation of Dalbias China rights

Dec 27, 2024 02:00 ET

Solasia Pharma KK: Business Status of Product Development Products, etc. (3rd quarter of the fiscal year ending 2024/12)

Nov 13, 2024 02:00 ET

Solasia Pharma KK: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

Nov 13, 2024 02:00 ET

Solasia Pharma KK: Confirmation letter

Aug 14, 2024 02:43 ET

Updated: Oct 18, 2024

Strong Buy

No Data

Overall

No Data

4597 Solasia Pharma KK

Solasia Pharma KK Key Stats